9-ING-41
Catalog No.
BA2793
9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective inhibitor of glycogen synthase kinase-3β.
Featured Products
9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective inhibitor of glycogen synthase kinase-3β with a value of 0.71 μM. 9-ING-41 significantly causes cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 exhibits anticancer activity and has the potential to potentiate the antitumor effects of chemoactive molecules.
| Physical Appearance | A solid |
| Storage | -20°C |
| M.Wt | 404.35 |
| Cas No. | 1034895-42-5 |
| Formula | C22H13FN2O5 |
| Synonyms | Elraglusib |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |